Acupuncture for amnestic mild cognitive impairment: Study protocol for a multicenter, single-blinded, long-term, randomized controlled trial

X Xinyue Zhang Z Ziwen Wang M Mingsheng Sun Q Qiongnan Bao Z Ziwen Chen Y Yiwei Liu (Department of Chemistry) Z Ziqi Wang (Division of Advanced Materials) F Fang Ye Z Zuoqin Yang X Xiaoli Du H Hong Zhang X Xin Mou X Xia He D Dehua Li K Kexin Wu J Jin Yao (School of Management, Shenzhen Polytechnic University) W Wanqi Zhong P Ping Xu S Shiqi Yang (State Key Laboratory for Mesoscopic Physics and Frontiers Science Center for Nano-optoelectronics, School of Physics) L Ling Zhao (National Key Laboratory of Agricultural Microbiology) Z Zihan Yin F Fanrong Liang

Abstract

Background Amnestic mild cognitive impairment (aMCI), a common neurodegenerative disease affecting older adults, has garnered significant research interest over the past few years. While previous studies have suggested that acupuncture holds promise as a clinical intervention to improve cognitive function in patients with aMCI, the long-term effect of acupuncture treatment for aMCI remains unclear. Methods This is a multicenter, single-blinded, randomized controlled trial (RCT) with a long-term follow-up.166 patients diagnosed with aMCI will be randomly divided into acupuncture group (AG) and sham acupuncture group (SA). The intervention will last for 12 weeks (2 sessions per week), follow-up for 48 weeks, and the study will last a total of 60 weeks. The primary outcomes are the changes in the Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-Cog) score from baseline to week 12 and from baseline to week 60. Generalized estimating equations (GEE) will be used to assess the impact of the acupuncture intervention on outcome variables over time at baseline and weeks 12, 24, 48, and 60. Discussion This protocol outlines a detailed procedure for a multicenter RCT designed to further evaluate the long-term effect of acupuncture in managing aMCI. We anticipate that the findings of this research will provide valuable insights and evidence-based recommendations for the clinical management of this patient population. Trial registration The trial was registered at Chinese Clinical Trial Registry on 28 May 2024 (Number: ChiCTR2400084932).

Article Details

Journal PLoS ONE
Volume / Issue Vol. 21, Issue 4
Published April 20, 2026
Pages e0346717
ISSN 1932-6203
Publisher Public Library of Science

Journal Info

PLoS ONE

Public Library of Science

ISSN: 1932-6203 Open Access Health Sciences

Authors (22)

X

Xinyue Zhang

Z

Ziwen Wang

M

Mingsheng Sun

Q

Qiongnan Bao

Z

Ziwen Chen

Y

Yiwei Liu

Department of Chemistry

Z

Ziqi Wang

Division of Advanced Materials

F

Fang Ye

Z

Zuoqin Yang

X

Xiaoli Du

H

Hong Zhang

X

Xin Mou

X

Xia He

D

Dehua Li

K

Kexin Wu

J

Jin Yao

School of Management, Shenzhen Polytechnic University

W

Wanqi Zhong

P

Ping Xu

S

Shiqi Yang

State Key Laboratory for Mesoscopic Physics and Frontiers Science Center for Nano-optoelectronics, School of Physics

L

Ling Zhao

National Key Laboratory of Agricultural Microbiology

Z

Zihan Yin

F

Fanrong Liang